Company Search:
Advanced Search
Sponsored Links
Whanin Pharmaceutical Company Limited Company Snapshot
Whanin Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Whanin Pharmaceutical Company Limited with three other companies in this sector in South Korea: Myungmoon Pharmaceutical Company Limited (2018 sales of 147.50 billion Korean Won [US$130.24 million] of which 97% was Manufacture and Sale of Pharmaceuticals), JW Life Science Corp (155.23 billion Korean Won [US$137.07 million] ), and Sam Chun Dang Pharm Co Ltd (159.96 billion Korean Won [US$141.24 million] of which 90% was Finished Goods).

Sales Analysis. During the year ended December of 2018, sales at Whanin Pharmaceutical Company Limited were 154.66 billion Korean Won (US$136.57 million). This is an increase of 4.5% versus 2017, when the company's sales were 147.95 billion Korean Won. Sales of Others saw an increase that was more than double the company's growth rate: sales were up 31.0% in 2018, from 4.15 billion Korean Won to 5.44 billion Korean Won. Whanin Pharmaceutical Company Limited also saw significant increases in sales in Afentac (up 12.8% to 4.08 billion Korean Won) . Not all segments of Whanin Pharmaceutical Company Limited experienced an increase in sales in 2018: sales of Atorvin fell 6.7% to 9.69 billion Korean Won. Whanin Pharmaceutical Company Limited also experienced decreases in sales in Urantac (down 1.8% to 8.94 billion Korean Won) and Proiban (down 3.1% to 5.17 billion Korean Won) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Whanin Pharmaceutical Company Limited
  Stock Performance Chart for Whanin Pharmaceutical Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (4/19/2019): 19,000
(Figures in Korean Won)
1 Week -0.5%   13 Weeks 0.5%  
4 Weeks 3.0%   52 Weeks -19.0%  
Whanin Pharmaceutical Company Limited Key Data:
  Ticker: 016580 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 154,664,330,714
(Year Ending Jan 2019).
Employees: 462
  Currency: Korean Won Market Cap: 290,074,330,000
  Fiscal Yr Ends: December Shares Outstanding: 15,267,070
  Share Type: Common Closely Held Shares: 3,945,170
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.